Tag: breast cancer trial

Lilly’s breast cancer drug abemaciclib meets objective in phase 3 trial

pharmanewsdaily- March 22, 2017

Indianapolis-based Lilly has reported that its breast cancer drug, abemaciclib, in combination with fulvestrant, has yielded positive results by meeting its primary endpoint, progression-free survival ... Read More